Article info
Viewpoint
Implementing post-trial access plans for HIV prevention research
- Correspondence to Dr Amy Paul, Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD 21205, USA; apaul7{at}jhu.edu
Citation
Implementing post-trial access plans for HIV prevention research
Publication history
- Received October 23, 2017
- Revised December 10, 2017
- Accepted February 5, 2018
- First published February 27, 2018.
Online issue publication
April 26, 2018
Article Versions
- Previous version (27 February 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Developing ethics guidance for HIV prevention research: the HIV Prevention Trials Network approach
- Addressing ethical challenges in HIV prevention research with people who inject drugs
- The challenge of defining standards of prevention in HIV prevention trials
- Post-trial access to study medication: a Brazilian e-survey with major stakeholders in clinical research
- Investigation of post-trial access views among study participants and stakeholders using photovoice and semistructured interviews
- Attitudes towards participating in research involving digital pill systems to measure oral HIV pre-exposure chemoprophylaxis: a cross-sectional study among men who have sex with men with substance use in the USA
- Recent advances in pre-exposure prophylaxis for HIV
- Female and younger subjects have lower adherence in PrEP trials: a meta-analysis with implications for the uptake of PrEP service to prevent HIV
- Acceptability of multiple modalities of pre-exposure prophylaxis (PrEP) among female sex workers in Tanzania: a mixed-methods study
- Should post-trial provision of beneficial experimental interventions be mandatory in developing countries?